Metagenomi • MGX
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$282.2M
Market Cap • 26/04/20242016
(há 8 anos)
2024
IPONASDAQ
Listagem
Emeryville
Sede • CaliforniaValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MGXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.